What were the primary drivers of Intuitive Surgical's revenue growth in the second quarter of 2007?

Revenue growth was primarily driven by the continued adoption of the da Vinci Surgical System across various surgical procedures, particularly prostatectomy and hysterectomy. This led to increased sales of both the capital systems themselves and recurring revenue from instruments, accessories, and services. Higher average selling prices for newer models like the da Vinci S and da Vinci S HD systems also contributed.

How did the company's profitability perform in the reported period?

Profitability saw significant improvement. Operating income increased by 84% year-over-year in Q2 2007 to $45.0 million, with an expanded operating margin of 32%. Net income more than doubled from $16.7 million to $30.7 million, resulting in a substantial increase in diluted Earnings Per Share (EPS) from $0.44 to $0.79.

What is the company's financial position and liquidity like?

Intuitive Surgical maintains a strong financial position and excellent liquidity. As of June 30, 2007, total assets reached $808.7 million. The company ended the quarter with $447.5 million in cash, cash equivalents, and investments. Operating activities generated $73.7 million in cash flow for the first half of 2007, underscoring its ability to fund operations and growth initiatives.

Are there any significant new product developments or strategic initiatives mentioned?

Yes, the company launched a high-definition (HD) vision system in early 2007, enhancing visualization capabilities. Other new product introductions in Q2 2007 included a 3-arm da Vinci S Surgical System, a Vision Cart Touchscreen, and an 8mm Bladeless Obturator. Strategically, the company is also streamlining its international operations by moving its headquarters to Switzerland, anticipating long-term tax structure optimization.

ISRG 10-Q Quarterly Report Q2 FY2007 — Revenue, Net Income, EPS

Summary

Intuitive Surgical Inc. (ISRG) demonstrated robust financial performance in the second quarter and the first half of 2007, driven by significant growth in revenue and operational efficiency. Total revenue surged by 61% year-over-year in Q2 2007 to $140.2 million, with a substantial 70% increase in recurring revenue to $66.1 million. This growth was fueled by increased adoption of the da Vinci Surgical System across various surgical specialties, particularly prostatectomy and hysterectomy procedures. The company also saw strong unit sales of its surgical systems, complemented by higher sales of instruments and accessories. Profitability also improved, with operating income rising 84% in Q2 2007 to $45.0 million. The company maintained healthy gross margins, with product gross profit at 70% and service gross profit at 49%. Despite increased investments in R&D and SG&A to support growth, ISRG reported a net income of $30.7 million for the quarter, a significant increase from $16.7 million in the prior year. The company's balance sheet remains strong, with cash, cash equivalents, and investments increasing to $447.5 million, reflecting its ability to generate substantial cash flow from operations.

Key Highlights

1Total revenue for Q2 2007 increased by 61% year-over-year to $140.2 million, with a 70% increase in recurring revenue to $66.1 million.
2da Vinci Surgical System unit sales increased by 44% in Q2 2007 to 56 units, compared to 39 units in Q2 2006.
3Instruments and accessories revenue grew by 76% in Q2 2007, indicating strong procedure volume growth.
4Operating income increased significantly by 84% in Q2 2007 to $45.0 million, with operating margin improving to 32% from 28% in the prior year.
5Net income for Q2 2007 more than doubled year-over-year to $30.7 million, with diluted EPS rising to $0.79 from $0.44.
6Cash, cash equivalents, and investments totaled $447.5 million as of June 30, 2007, demonstrating a strong liquidity position.
7The company continues to invest in R&D and product development, launching new HD vision systems and other system enhancements.

INTUITIVE SURGICAL INC Quarterly Report for Q2 Ended Jun 30, 2007

Summary

Key Highlights

Frequently Asked Questions